Acetaminophen
NDC 45014-130
Product Information
Acetaminophen is a OTC MONOGRAPH FINAL-approved product labeled by Accudial Pharmaceutical, Inc.. This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. It is supplied as a red product. This product entry covers the primary NDC 45014-130 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 45014-130?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- SORBITOL (UNII: 506T60A25R)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- WATER (UNII: 059QF0KO0R)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- PRUNUS SEROTINA BARK (UNII: 5D48E975HA)
- POLYETHYLENE GLYCOL 1450 (UNII: OJ4Z5Z32L4)
- D&C RED NO. 33 (UNII: 9DBA0SBB0L)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 307675 - acetaminophen 160 MG in 5 mL Oral Solution
- RxCUI: 307675 - acetaminophen 32 MG/ML Oral Solution
- RxCUI: 307675 - acetaminophen 160 MG per 5 ML Oral Solution
- RxCUI: 307675 - acetaminophen 325 MG per 10.15 ML Oral Solution
- RxCUI: 307675 - acetaminophen 650 MG per 20.3 ML Oral Solution
* Please review the full disclaimer at the bottom of this page.